Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 264
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #206: Q2’25 Psychedelic Lobbying; Tabernanthalog’s Neuroplasticity Pathway; UK Moves to Ease Schedule I Research Restrictions
GLP-1 Drugs, Psilocybin Mushrooms, and the Case for Sublingual Psilocin
Therapy or Threat? UK Expert Warns of Rising Ketamine Addiction as Phase III Alcoholism Trial Launches
The Psychedelic News Feed: January 5 – June 1, 2025
Pα+ Psychedelic Bulletin #205: AbbVie Eyes Gilgamesh; Psychedelics Use Increases in U.S.; FDA Moves to Ban Kraton Compound 7-OH; What Is Sinema Selling?
Psychedelic Synesthesia: Smell That Tune
Cybin Signs Drug Development Agreement with Catalent for its Fast-Dissolve Formulation...
Mindset Pharma Announces $5 Million Bought Deal Financing
MindMed Announces Inclusion in FTSE Russell Indexes
Psychedelic Bulletin: Australian Gov Earmarks $15m for Psychedelic Studies; Otsuka Licences...
Numinus Announces Closing of $40-Million Bought Deal Financing
Red Light Holland Closes Acquisition of SR Wholesale Becoming a Leader...
PTSF51 – Miracle Cures, Money, and Standing on the Shoulders of...
Ty Tashiro joins MINDCURE as the Senior Translational and Psychometric Architect...
Revive Therapeutics Announces Successful Research Results for Psilocybin to Treat Traumatic...
1
...
263
264
265
...
294
Page 264 of 294
